August 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating the agreement between Dayforce Inc. (“Dayforce”) (NYSE: DAY) and Thoma Bravo. Investors who purchased Dayforce and continue to hold to the present are encouraged to obtain additional information and assist the investigation. Investigation Details The investigation concerns whether… read more
August 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tandem Diabetes Care, Inc. (“Tandem” or “the Company”) (NASDAQ: TNDM). Investors who purchased Tandem securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Tandem has… read more
August 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating claims on behalf of investors in Soho House & Co Inc. (“Soho House” or “the Company”) (NYSE: SHCO) for potential breaches of fiduciary duty on the part of its directors and management. Investors who purchased Soho House and… read more
August 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Broadwind, Inc. (“Broadwind” or “the Company”) (NASDAQ: BWEN). Investors who purchased Broadwind securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Broadwind has violated federal… read more
August 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CPI Card Group Inc. (“CPI” or “the Company”) (NASDAQ: PMTS). Investors who purchased CPI securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CPI has… read more
August 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Align Technology, Inc. (“Align” or “the Company”) (NASDAQ: ALGN). Investors who purchased Align securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Align has violated… read more
August 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bumble Inc. (“Bumble” or “the Company”) (NASDAQ: BMBL). Investors who purchased Bumble securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Bumble has violated federal… read more
August 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Praxis Precision Medicines, Inc. (“Praxis” or “the Company”) (NASDAQ: PRAX). Investors who purchased Praxis securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Praxis has… read more
August 13, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The J. M. Smucker Company (“Smucker” or “the Company”) (NYSE: SJM). Investors who purchased Smucker securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Smucker… read more
August 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Trade Desk, Inc. (“Trade Desk” or “the Company”) (NASDAQ: TTD). Investors who purchased Trade Desk securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Collective Mining Ltd. (“Collective Mining” or “the Company”) (NYSE: CNL). Investors who purchased Collective Mining securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Collective… read more
August 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Confluent, Inc. (“Confluent” or “the Company”) (NASDAQ: CFLT). Investors who purchased Confluent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Confluent has violated federal… read more
August 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Albany International Corp. (“Albany” or “the Company”) (NYSE: AIN). Investors who purchased Albany securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Albany has violated… read more
August 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exelixis, Inc. (“Exelixis” or “the Company”) (NASDAQ: EXEL). Investors who purchased Exelixis securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Exelixis has violated federal… read more
July 28, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Simulations Plus, Inc. (“Simulations” or “the Company”) (NASDAQ: SLP). Investors who purchased Simulations securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Simulations has violated… read more
July 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Geely Automobile Holdings Limited (“Geely” or “the Company”) (OTCMKTS: GELYF; GELYY). Investors who purchased Geely securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Geely… read more
July 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ZEEKR Intelligent Technology Holding Limited (“Zeekr” or “the Company”) (NASDAQ: ZK). Investors who purchased Zeekr securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Zeekr… read more
July 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GSK plc (“GSK” or “the Company”) (NYSE: GSK). Investors who purchased GSK securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GSK has violated federal… read more
July 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Edgewise Therapeutics, Inc. (“Edgewise” or “the Company”) (NASDAQ: EWTX). Investors who purchased Edgewise securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Edgewise has violated… read more
July 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Proficient Auto Logistics, Inc. (“Proficient Auto” or “the Company”) (NASDAQ: PAL). Investors who purchased Proficient Auto securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
July 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Laser Photonics Corporation (“Laser Photonics” or “the Company”) (NASDAQ: LASE). Investors who purchased Laser Photonics securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Laser… read more
July 13, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Funko, Inc. (“Funko” or “the Company”) (NASDAQ: FNKO). Investors who purchased Funko securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Funko has violated federal… read more
July 11, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Civitas Resources, Inc. (“Civitas” or “the Company”) (NYSE: CIVI). Investors who purchased Civitas securities prior to February 27, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
July 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Compass Diversified Holdings (“Compass” or “the Company”) (NYSE: CODI). Investors who purchased Compass securities prior to March 1, 2023, and continue to hold to the present, are encouraged to obtain additional… read more
July 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of West Pharmaceutical Services, Inc. (“West” or “the Company”) (NYSE: WST). Investors who purchased West securities prior to February 16, 2023, and continue to hold to the present, are encouraged to obtain… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bakkt Holdings, Inc. (“Bakkt” or “the Company”) (NYSE: BKKT). Investors who purchased Bakkt securities prior to March 25, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Open Lending Corporation (“Open Lending” or “the Company”) (NASDAQ: LPRO). Investors who purchased Open Lending securities prior to February 24, 2022, and continue to hold to the present, are encouraged to… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NAPCO Security Technologies, Inc. (“NAPCO” or “the Company”) (NASDAQ: NSSC). Investors who purchased NAPCO securities prior to February 5, 2024, and continue to hold to the present, are encouraged to obtain… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. (“Avis Budget” or “the Company”) (NASDAQ: CAR). Investors who purchased Avis Budget securities prior to February 13, 2024, and continue to hold to the present, are encouraged… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sana Biotechnology, Inc. (“Sana” or “the Company”) (NASDAQ: SANA). Investors who purchased Sana securities prior to March 17, 2023, and continue to hold to the present, are encouraged to obtain additional… read more